The Cytokinesis Blocked Micronucleus Assay as a Strong Predictor of Lung Cancer: Extension of a Lung cancer risk prediction model

BACKGROUND: There is an urgent need to improve lung cancer outcome by identifying and validating markers of risk. We previously reported that the cytokinesis-blocked micronucleus assay (CBMN) is a strong predictor of lung cancer risk. Here we validate our findings in an independent external lung can...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Epidemiol Biomarkers Prev
Egile Nagusiak: El-Zein, Randa A., Lopez, Mirtha S., D’Amelio, Anthony M., Liu, Mei, Munden, Reginald F., Christiani, David, Su, Li, Tejera-Alveraz, Paula, Zhai, Rihong, Spitz, Margaret R., Etzel, Carol J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4487661/
https://ncbi.nlm.nih.gov/pubmed/25172871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-14-0462
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak